Scientists reverse Alzheimer’s in mice: Scientists reverse Alzheimer’s in mice — breakthrough sparks hope for humans

In what experts describe as a major step towards defeating dementia, scientists have successfully reversed Alzheimer’s disease in mice using a groundbreaking new treatment. The therapy, developed by Spanish and Chinese researchers, uses nanoparticles to restore the brain’s natural ability to clear toxic buildup that hinders cell communication. The treatment allowed the mice’s brains to recover by “reminding” the blood-brain barrier how to function properly, showing a dramatic recovery in just an hour. The findings offer new hope that Alzheimer’s disease, the most common cause of dementia, may one day be treated, The Telegraph reports.
ALSO READ:National Taco Day 2025: $1 tacos are back! Don’t miss Taco Bell’s epic deals

How does the new treatment target Alzheimer’s?

Researchers from Spain and China have discovered a way to restore the function of the blood-brain barrier, a protective system that regulates what enters and exits the brain. In Alzheimer’s patients, this gatekeeping process becomes blocked and inefficient, causing toxic amyloid beta plaques to accumulate and damage neurons.

To solve this, scientists have developed nanoparticles that are injected into the bloodstream. According to a report by The Telegraph, these particles travel to the blood-brain barrier, bind to it, and stimulate natural mechanisms that help the brain clear waste and absorb nutrients more effectively; This teaches how to make the barrier work properly again.ALSO READ: Amazon Prime payouts: Find out if you’re eligible for a refund

What did scientists observe after the injection?

When tested on mice genetically programmed to produce large amounts of amyloid beta, mimicking Alzheimer’s symptoms, the results were immediate and dramatic.

“Just one hour after injection, we observed a 50-60 percent reduction in the amount of amyloid beta in the brain,” said study first co-author Junyang Chen, a researcher at West China Hospital of Sichuan University and a PhD student at University College London (UCL), according to a report by The Telegraph.

Further behavioral testing revealed even more promise. In one experiment, a 12-month-old mouse, roughly equivalent to a 60-year-old human, was treated with nanoparticles and observed six months later. The behavior of the treated mouse became the same as that of a healthy mouse; This shows that brain function has fully recovered.

How does treatment restore brain functions?

The therapy mimics a natural protein called LRP1, which recognizes amyloid beta and transports it across the blood-brain barrier. Once the barrier returns to its normal activity, it continues to clear harmful substances, improve blood flow, reduce brain inflammation and allow the system to regain balance, The Telegraph reports.

ALSO READ: Pam Bondi’s impassioned testimony at Senate hearing following Dick Durbin’s questioning – important things to know

Professor Giuseppe Battaglia of the Catalan Institute for Research and Advanced Studies (ICREA), who led the research, said: “The progress made so far is extremely encouraging; repairing the brain barrier could open a new way to treat not only Alzheimer’s but also other neurological diseases.”

Battaglia added that if results remain the same in larger studies, human clinical trials could begin within the next few years, according to The Telegraph’s report.

Prof Giuseppe Battaglia, from the Catalan Institute for Research and Advanced Studies, said: “We are optimistic that the benefits we have seen (improved blood flow, reduced brain inflammation and improved barrier) will also be reflected in humans. The blood-brain barrier plays a similar role in all of us, so helping it recover could make a real difference in our fight against Alzheimer’s and other forms of dementia.”

What’s next for Alzheimer’s research?

There are currently no licensed drugs that can reverse Alzheimer’s, a disease that affects around 944,000 people in Britain, with the number expected to exceed one million by 2030. The condition now stands as the leading cause of death in the UK, costing the country an estimated £34.7 billion, The Telegraph reports.

The researchers aim to begin larger preclinical studies before moving on to human testing. Their study, published in the journal Signal Transduction and Targeted Therapy, suggests that restoring the brain’s natural defenses may be the key to stopping or even reversing dementia.

FAQ

How does this Alzheimer’s treatment work?
The nanoparticles “remind” the blood-brain barrier to clear amyloid beta, allowing brain cells to communicate normally again.

When can human trials begin?
Researchers are first planning larger preclinical studies, but if funding becomes available, early clinical trials could begin within a few years.